Podcast: Retina UK Day
We sat down to discuss what our volunteers got up to on Retina UK day.
Search
Search results
Nanoscope Announces topline results from randomised phase 2B trial of MCO-010 for retinitis pigmentosa
Nanoscope Therapeutics has announced positive results from their two year randomised controlled phase 2b optogenetic therapy trial for late-stage retinitis pigmentosa (RP).
How we can work together
We can provide all the support your organisation needs to work with us; from ideas to practical support and materials. The Retina UK team will help your contribution be as fun and rewarding as possible.
New Chair of Trustees
We are delighted to welcome Kathy Evans as our new Chair of Trustees.
Virtual delegate bag
A virtual delegate bag for our online attendees - Professionals' Conference 2024
Belfast Local Peer Support Group
Thursday 12 June, 7.00pm - 8.00pm - Online - Come and join Kim, Annmarie and the Belfast Bumpers Group for a social catch up and to hear from our guest speaker Ann-Marie Houston.
How we can support you in your role
Whether you are a professional looking for practical information for yourself, or practical or emotional support for your clients, online, by phone or face-to-face, we're here to help. All of our services are free to access and offered in a range of accessible formats.
Online information & support
Retina UK has a number of online support resources which we offer via social media.
About Unlock Genetics
The aim of the site is to increase the level of awareness and understanding of genetic testing and genetic counselling among people living with inherited retinal dystrophies, empowering them to make fully informed decisions about their lives, healthcare and family planning.
ProQR announces suspension of LCA10 and USH2A clinical trials
Biotechnology company ProQR has announced that its clinical trials of sepofarsen for Leber congenital amaurosis type 10 and ultevursen for USH2A-mediated retinitis pigmentosa will be wound down with immediate effect.